• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Asia-Pacific Glaucoma Treatment Market Research Report- Forecast to 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Asia Pacific Glaucoma Treatment Market

    ID: MRFR/Pharma/2176-HCR
    70 Pages
    Rahul Gotadki
    September 2025

    Asia-Pacific Glaucoma Treatment Market Share, Trends And Growth Analysis By Disease Indication (Closed Angle Glaucoma (Cag), Open Angle Glaucoma (Oag), Secondary Glaucoma, Congenital Glaucoma And Other), Drug Class (Prostaglandin Analogs (Pgas), Alpha Agonist, Beta Blockers, Cholinergic Drugs, Carbonic Anhydrase Inhibitors, And Others), Surgery (Laser Iridotomy, Laser Trabeculoplasty, Aqueous Shunt Surgery And Peripheral Iridectomy) And By End Users (Hospitals And Home Users) - Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Asia-Pacific Glaucoma Treatment Market Research Report- Forecast to 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Asia Pacific Glaucoma Treatment Market Summary

    As per Market Research Future Analysis, the Asia-Pacific Glaucoma Treatment Market was valued at USD 1.34 Billion in 2023 and is projected to grow significantly. The market is driven by an increasing geriatric population, heightened awareness, and rising healthcare expenditures. Glaucoma, primarily affecting older adults, poses a risk of blindness if untreated, with open-angle glaucoma being the most prevalent type. The market is also influenced by advancements in surgical options and product development, although challenges exist due to the efficacy of existing treatments and patent expirations.

    Key Market Trends & Highlights

    The Asia-Pacific Glaucoma Treatment Market is experiencing robust growth driven by demographic and healthcare trends.

    • Market Size in 2023: USD 1.34 Billion.
    • Projected Market Size by 2032: USD 3.14 Billion.
    • CAGR from 2024 to 2032: 8.71%.
    • Key players include Novartis AG, Pfizer Inc., and Merck & Co.

    Market Size & Forecast

    2023 Market Size USD 1.34 Billion
    2024 Projected Market Size USD 1.48 Billion
    2032 Projected Market Size USD 3.14 Billion

    Major Players

    Key players in the Asia-Pacific Glaucoma Treatment Market include Novartis AG, Pfizer Inc., Allergan, Merck & Co., Ocular Therapeutix Inc, pSivida Corp, and others.

    Asia Pacific Glaucoma Treatment Market Trends

    Asia Pacific Glaucoma Treatment Market Drivers

    Market Segment Insights

    Asia-Pacific Glaucoma Treatment Disease Indication Insights

    On the basis of disease indication which comprises Closed Angle Glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. 

    Asia-Pacific Glaucoma Treatment Drug Class Insights

    On the basis of drug class market is segmented into prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others. 

    Asia-Pacific Glaucoma Treatment Surgery Insights

    On the basis of surgery market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. 

    Asia-Pacific Glaucoma Treatment End User Insights

    On the basis of end users market is segmented into hospitals and home users.

    Get more detailed insights about Asia-Pacific Glaucoma Treatment Market Research Report- Forecast to 2032

    Request Free Sample

    Regional Insights

    Key Companies in the Asia Pacific Glaucoma Treatment Market market include

    Industry Developments

    Market Segmentation

    Report Scope

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    1. 'Table of Contents
    2. Introduction
      1. Definition
      2. Scope of Study
      3. Research Objective
      4. Assumptions &
    3. Limitations
    4. Market Structure:
    5. Research Methodology
    6. Research Process
    7. Primary Research
    8. Secondary Research
    9. Market Dynamics
    10. Drivers
    11. Restraints
    12. Opportunities
    13. Challenges
    14. Macroeconomic Indicators
    15. Market Factor Analysis
      1. Porter’s five forces model
        1. Bargaining Power of suppliers
        2. Bargaining Power of Customer
        3. Intensity of Competitor’s
        4. Threat of New Entrants
    16. Asia-Pacific Glaucoma
    17. Treatment Market, by Disease Indication
      1. Introduction
        1. Closed Angle Glaucoma (CAG)
        2. Open Angle Glaucoma (OAG)
        3. Secondary Glaucoma
        4. Congenital Glaucoma
        5. Other
    18. Asia-Pacific Glaucoma
    19. Treatment Market, by Drug class
      1. Introduction
        1. Prostaglandin Analogs (PGAs)
        2. Alpha Agonist
        3. Beta Blockers
        4. Cholinergic Drugs
        5. Carbonic Anhydrase Inhibitors
        6. Others
    20. Asia-Pacific Glaucoma Treatment
    21. Market, by Surgery
    22. Introduction
    23. Laser Iridotomy
    24. Laser Trabeculoplasty
    25. Aqueous Shunt Surgery
    26. Peripheral Iridectomy
    27. Asia-Pacific Glaucoma Treatment Market, by End Users
      1. Introduction
        1. Hospitals
        2. Home Users
    28. Africa Medical Devices Market, by Country
      1. Introduction
      2. Japan
      3. China
      4. India
      5. Australia
      6. Kazakhstan
      7. Rest of Asia Pacific
    29. Company Landscape
      1. Introduction
        1. Mergers Acquisitions
        2. Collaborations
        3. Release/New Product Launches
        4. Other (Expansion, Updates,
    30. Partnership)
    31. Company Profile
    32. Novartis AG
    33. Company Overview
    34. Product/Business Segment Overview
      1. Financials
        1. Key Developments
        2. SWOT Analysis
      2. Pfizer Inc.
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      3. Allergan
        1. Overview
        2. Product/Business
    35. Segment Overview
    36. Financials
    37. Key Developments
    38. SWOT Analysis
    39. Merck & Co.
    40. Overview
    41. Product/Business Segment Overview
      1. Financials
        1. Key Developments
        2. SWOT Analysis
      2. Ocular Therapeutix Inc
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      3. pSivida Corp
        1. Overview
        2. Product/Business
    42. Segment Overview
    43. Financials
    44. Key Developments
    45. SWOT Analysis
    46. Icon Bioscience Inc.
    47. Overview
    48. Product/Business Segment Overview
      1. Financials
        1. Key Developments
        2. SWOT Analysis
      2. Amorphex Therapeutics LLC.
        1. Overview
        2. Product/Business Segment
    49. Overview
    50. Financials
    51. Key Developments
    52. SWOT Analysis
    53. Ellex
    54. Overview
    55. Product/Business Segment Overview
      1. Financials
        1. Key Developments
        2. SWOT Analysis
      2. Quantel
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      3. Lumenis
        1. Overview
        2. Product/Business
    56. Segment Overview
    57. Financials
    58. Key Developments
    59. SWOT Analysis
    60. Lightmed
    61. Overview
    62. Product/Business Segment Overview
      1. Financials
        1. Key Developments
        2. SWOT Analysis
      2. Others
    63. Appendix
    64. (USD MILLION)
    65. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY DISEASE INDICATION, 2020-2027 (USD
    66. MILLION)
    67. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
    68. GLAUCOMA TREATMENT MARKET, BY SURGERY, 2020-2027 (USD MILLION)
    69. TREATMENT MARKET, BY END USERS, 2020-2027 (USD MILLION)
    70. REGION, 2020-2027 (USD MILLION)
    71. TREATMENT MARKET, BY DISEASE INDICATION
    72. CLASS
    73. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY SURGERY
    74. BY END USERS
    75. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY REGION
    76. COMPANY SHARE ANALYSIS, 2020 (%)'

    Asia-Pacific Glaucoma Treatment Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Asia-Pacific Glaucoma Treatment Market Research Report- Forecast to 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027